| Peer-Reviewed

Therapeutic Benefit of Addition of Cetirizine to Ambroxol in Fixed Dose Combination in the Treatment of Productive Cough in Children: A Prospective, Multi-center Study

Received: 28 January 2017     Accepted: 14 February 2017     Published: 28 November 2017
Views:       Downloads:
Abstract

Productive cough is a common problem in children and is accompanied by disruption of sleep and routine daily activities leading to a deterioration in quality of life. We evaluated the efficacy, safety and tolerability of cetirizine and ambroxol fixed dose combination (FDC) as compared with ambroxol in these patients. We conducted open-label, prospective, multicenter study attending outpatient department with cough ≥12 hours; were screened to receive either cetirizine and ambroxol FDC (AC group) or ambroxol alone (AX group). Primary efficacy variables were evaluation of total symptom score (TSS) for cough and secondary efficacy variables included evaluation of total nasal symptom score (TNSS); assessment of cough frequency; number of awakenings due to cough; and time to complete relief. Out of 250 children included, 246 completed the study with a statistically significant improvement in TSS from baseline to day 3 (p=0.029) and day 7 (p=0.048) in the AC group as compared with AX group. Improvement in TNSS was better in the AC group from baseline to day 3 (p<0.0001) and day 7 (p=0.016) as compared with the AX group. Greater proportion of children in the AC group recovered completely from cough by day 7 (97.67%) as compared with the AX group (78.63%). As side effects, only two children of the AC group experienced mild AEs (drowsiness). We thus conclude that FDC demonstrated improved efficacy and safety and was well tolerated as compared with ambroxol alone in children with productive cough.

Published in American Journal of Internal Medicine (Volume 5, Issue 6)
DOI 10.11648/j.ajim.20170506.14
Page(s) 129-135
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2017. Published by Science Publishing Group

Keywords

Cetirizine, Ambroxol, Productive Cough, Children, Total Symptom Score

References
[1] World Health Organization. Cough and Cold Remedies for the Treatment of Acute Respiratory Infections in Young Children. 2001. Available from: http://apps.who.int/iris/bitstream/10665/66856/1/WHO_FCH_CAH_01.02.pdf. Accessed on 14 Jan 2016.
[2] Morice A. H. and Kastelik. J. A. Cough. 1: Chronic cough in adults. Thorax 2003; 58: 901-7.
[3] Dicpinigaitis PV, Colice GL, Goolsby MJ, Rogg GI, Spector SL, Winther B. Acute cough: a diagnostic and therapeutic challenge. Cough 2009; 5: 11.
[4] Carter E. R., DebleyJ. S, and Redding G. R. Chronic productive cough in school children: prevalence and associations with asthma and environmental tobacco smoke exposure. Cough 2006; 2: 11.
[5] Worrall G. Acute cough in children. Canadian Family Physician 2011; 57: 315-8.
[6] Asthma Foundation. What is a chronic persistent wet cough? 2010 [cited 2016 15 Jan 2016]; Available from: http://asthmafoundation.org.nz/wp-content/uploads/2012/03/Whatis_PersistentWetCough.pdf. Accessed on 14 Jan 2016.
[7] Goldsobel, A. B. and Chipps B. E. Cough in the pediatric population. J Pediatr 2010; 156: 352-8.
[8] Chang, A. B, Oppenheimer J. J, Weinberger M, Rubin B. K, Irwin R. S. Children With Chronic Wet or Productive Cough-Treatment and Investigations: A Systematic Review. Chest 2016; 149: 120-42.
[9] Dhar R. Role of mucolytics in wet cough. J Assoc Physicians India 2013; 61: 23-7.
[10] Malerba M. and Ragnoli B. Ambroxol in the 21st century: pharmacological and clinical update. Expert Opin Drug Metab Toxicol 2008; 4: 1119-29.
[11] Ciprandi G, Tosca M, Ricca V, Passalacqua G, Fregonese L, Fasce L, et al. Cetirizine treatment of allergic cough in children with pollen allergy. Allergy 1997; 52: 752-4.
[12] Del Cuvillo A, Sastre J, Montoro J, Jauregui I, Ferrer M, Davila I, et al. Use of antihistamines in pediatrics. JInvestig Allergol Clin Immunol 2007; 17: 28-40.
[13] Ioan I, Poussel M, Coutier L, Plevkova J, Poliacek I, Bolser D.C et alWhat is chronic cough in children? Front Physiol 2014; 5: 322.
[14] Bailey E. J. and Chang A. In children with prolonged cough, does treatment with antibiotics have a better effect on cough resolution than no treatment?: Part A: Evidence-based answer and summary. Paediatr Child Health 2008; 13: 512-3.
[15] Bell D. S. Combine and conquer: advantages and disadvantages of fixed-dose combination therapy. Diabetes Obes Metab 2013; 15 291-300.
[16] Ibiapina Cda C, Sarinho ES, Camargos PA, Andrade CR, Cruz Filho AA. Allergic rhinitis: epidemiological aspects, diagnosis and treatment. J Bras Pneumol 2008; 34: 230-40.
[17] Demoly P, Calderon MA, Casale T, Scadding G, Annesi-Maesano I, Braun JJ, et al. Assessment of disease control in allergic rhinitis. Clin Transl Allergy 2013; 3: 7.
[18] Stoelzel K, Bothe G, Chong PW and Lenarz M. Safety and efficacy of Nasya/Prevalin in reducing symptoms of allergic rhinitis. Clin Respir J 2014; 8: 382-90.
[19] Benich J. J, Carek P. J. Evaluation of the Patient with Chronic Cough. American Family Physician 2011; 8: 887-92.
[20] Chung K. F. Currently available cough suppressants for chronic cough. Lung 2008; 18: p. S82-7.
[21] Shields M. D, Bush A, Everard M. L, McKenzie S, Primhak R. BTS guidelines: Recommendations for the assessment and management of cough in children. Thorax 2008; 63: iii1-iii15.
[22] Kelley L. K. and AllenP. J. Managing acute cough in children: evidence-based guidelines. Pediatr Nurs 2007; 33: 515-24.
[23] Ryan T, Brewer M, and Small L. Over-the-counter cough and cold medication use in young children. Pediatr Nurs 2008; 34: 174-80, 184.
[24] Dart R. C, Paul I. M, Bond G. R, Winston D. C, Manoguerra A. S, Palmer R. B, et al. Pediatric fatalities associated with over the counter (nonprescription) cough and cold medications. Ann Emerg Med 2009; 53: 411-7.
[25] Roy V, Malhotra R, Tayal V, Bansal A, Gupta KS. Fixed-dose combinations for cough and common cold in India: an assessment of availability and rationality. Fundam Clin Pharmacol 2011; 25: 258-66.
Cite This Article
  • APA Style

    Amit Garg, Bharath Venkata Ramisetty, Nirmal Choraria, Kirti Sisodiya, Monidipa Banerjee, et al. (2017). Therapeutic Benefit of Addition of Cetirizine to Ambroxol in Fixed Dose Combination in the Treatment of Productive Cough in Children: A Prospective, Multi-center Study. American Journal of Internal Medicine, 5(6), 129-135. https://doi.org/10.11648/j.ajim.20170506.14

    Copy | Download

    ACS Style

    Amit Garg; Bharath Venkata Ramisetty; Nirmal Choraria; Kirti Sisodiya; Monidipa Banerjee, et al. Therapeutic Benefit of Addition of Cetirizine to Ambroxol in Fixed Dose Combination in the Treatment of Productive Cough in Children: A Prospective, Multi-center Study. Am. J. Intern. Med. 2017, 5(6), 129-135. doi: 10.11648/j.ajim.20170506.14

    Copy | Download

    AMA Style

    Amit Garg, Bharath Venkata Ramisetty, Nirmal Choraria, Kirti Sisodiya, Monidipa Banerjee, et al. Therapeutic Benefit of Addition of Cetirizine to Ambroxol in Fixed Dose Combination in the Treatment of Productive Cough in Children: A Prospective, Multi-center Study. Am J Intern Med. 2017;5(6):129-135. doi: 10.11648/j.ajim.20170506.14

    Copy | Download

  • @article{10.11648/j.ajim.20170506.14,
      author = {Amit Garg and Bharath Venkata Ramisetty and Nirmal Choraria and Kirti Sisodiya and Monidipa Banerjee and Shyam Akku},
      title = {Therapeutic Benefit of Addition of Cetirizine to Ambroxol in Fixed Dose Combination in the Treatment of Productive Cough in Children: A Prospective, Multi-center Study},
      journal = {American Journal of Internal Medicine},
      volume = {5},
      number = {6},
      pages = {129-135},
      doi = {10.11648/j.ajim.20170506.14},
      url = {https://doi.org/10.11648/j.ajim.20170506.14},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajim.20170506.14},
      abstract = {Productive cough is a common problem in children and is accompanied by disruption of sleep and routine daily activities leading to a deterioration in quality of life. We evaluated the efficacy, safety and tolerability of cetirizine and ambroxol fixed dose combination (FDC) as compared with ambroxol in these patients. We conducted open-label, prospective, multicenter study attending outpatient department with cough ≥12 hours; were screened to receive either cetirizine and ambroxol FDC (AC group) or ambroxol alone (AX group). Primary efficacy variables were evaluation of total symptom score (TSS) for cough and secondary efficacy variables included evaluation of total nasal symptom score (TNSS); assessment of cough frequency; number of awakenings due to cough; and time to complete relief. Out of 250 children included, 246 completed the study with a statistically significant improvement in TSS from baseline to day 3 (p=0.029) and day 7 (p=0.048) in the AC group as compared with AX group. Improvement in TNSS was better in the AC group from baseline to day 3 (pp=0.016) as compared with the AX group. Greater proportion of children in the AC group recovered completely from cough by day 7 (97.67%) as compared with the AX group (78.63%). As side effects, only two children of the AC group experienced mild AEs (drowsiness). We thus conclude that FDC demonstrated improved efficacy and safety and was well tolerated as compared with ambroxol alone in children with productive cough.},
     year = {2017}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Therapeutic Benefit of Addition of Cetirizine to Ambroxol in Fixed Dose Combination in the Treatment of Productive Cough in Children: A Prospective, Multi-center Study
    AU  - Amit Garg
    AU  - Bharath Venkata Ramisetty
    AU  - Nirmal Choraria
    AU  - Kirti Sisodiya
    AU  - Monidipa Banerjee
    AU  - Shyam Akku
    Y1  - 2017/11/28
    PY  - 2017
    N1  - https://doi.org/10.11648/j.ajim.20170506.14
    DO  - 10.11648/j.ajim.20170506.14
    T2  - American Journal of Internal Medicine
    JF  - American Journal of Internal Medicine
    JO  - American Journal of Internal Medicine
    SP  - 129
    EP  - 135
    PB  - Science Publishing Group
    SN  - 2330-4324
    UR  - https://doi.org/10.11648/j.ajim.20170506.14
    AB  - Productive cough is a common problem in children and is accompanied by disruption of sleep and routine daily activities leading to a deterioration in quality of life. We evaluated the efficacy, safety and tolerability of cetirizine and ambroxol fixed dose combination (FDC) as compared with ambroxol in these patients. We conducted open-label, prospective, multicenter study attending outpatient department with cough ≥12 hours; were screened to receive either cetirizine and ambroxol FDC (AC group) or ambroxol alone (AX group). Primary efficacy variables were evaluation of total symptom score (TSS) for cough and secondary efficacy variables included evaluation of total nasal symptom score (TNSS); assessment of cough frequency; number of awakenings due to cough; and time to complete relief. Out of 250 children included, 246 completed the study with a statistically significant improvement in TSS from baseline to day 3 (p=0.029) and day 7 (p=0.048) in the AC group as compared with AX group. Improvement in TNSS was better in the AC group from baseline to day 3 (pp=0.016) as compared with the AX group. Greater proportion of children in the AC group recovered completely from cough by day 7 (97.67%) as compared with the AX group (78.63%). As side effects, only two children of the AC group experienced mild AEs (drowsiness). We thus conclude that FDC demonstrated improved efficacy and safety and was well tolerated as compared with ambroxol alone in children with productive cough.
    VL  - 5
    IS  - 6
    ER  - 

    Copy | Download

Author Information
  • Global Medical Affairs, Dr. Reddy’s Laboratories, Banjara Hills, Hyderabad, India

  • Narayana Medical College and Hospital, Opposite Narayana Engineering College, Chinthareddypalem, Nellore, India

  • Nirmal Hospital, Centre Point, Near Kadiwala School, Surat, India

  • BAPS Hospital, Shri Pramukh Swami Maharaj Marg, Adajan Char Rasta, Adajan, Surat, India

  • Peerless Hospital &`B.K. Roy Research Center360 Panchasayar, Kolkata, India

  • Global Medical Affairs, Dr. Reddy’s Laboratories, Banjara Hills, Hyderabad, India

  • Sections